Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $876.73 million. The enterprise value is -$47.27 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RCUS has 105.89 million shares outstanding. The number of shares has increased by 20.51% in one year.
Current Share Class | 105.89M |
Shares Outstanding | 105.89M |
Shares Change (YoY) | +20.51% |
Shares Change (QoQ) | +7.31% |
Owned by Insiders (%) | 4.37% |
Owned by Institutions (%) | 54.32% |
Float | 65.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.47 |
Forward PS | 6.57 |
PB Ratio | 1.65 |
P/TBV Ratio | 1.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.15.
Current Ratio | 5.37 |
Quick Ratio | 5.30 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -109.00 |
Financial Efficiency
Return on equity (ROE) is -63.17% and return on invested capital (ROIC) is -40.37%.
Return on Equity (ROE) | -63.17% |
Return on Assets (ROA) | -22.25% |
Return on Invested Capital (ROIC) | -40.37% |
Return on Capital Employed (ROCE) | -45.23% |
Revenue Per Employee | $224,880 |
Profits Per Employee | -$623,604 |
Employee Count | 627 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
Income Tax | 1.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.74% in the last 52 weeks. The beta is 0.87, so RCUS's price volatility has been lower than the market average.
Beta (5Y) | 0.87 |
52-Week Price Change | -45.74% |
50-Day Moving Average | 8.57 |
200-Day Moving Average | 13.70 |
Relative Strength Index (RSI) | 48.64 |
Average Volume (20 Days) | 1,244,008 |
Short Selling Information
The latest short interest is 7.91 million, so 7.47% of the outstanding shares have been sold short.
Short Interest | 7.91M |
Short Previous Month | 8.45M |
Short % of Shares Out | 7.47% |
Short % of Float | 12.05% |
Short Ratio (days to cover) | 5.96 |
Income Statement
In the last 12 months, RCUS had revenue of $141.00 million and -$391.00 million in losses. Loss per share was -$4.20.
Revenue | 141.00M |
Gross Profit | -320.00M |
Operating Income | -436.00M |
Pretax Income | -246.00M |
Net Income | -391.00M |
EBITDA | -426.00M |
EBIT | -436.00M |
Loss Per Share | -$4.20 |
Full Income Statement Balance Sheet
The company has $997.00 million in cash and $81.00 million in debt, giving a net cash position of $924.00 million or $8.73 per share.
Cash & Cash Equivalents | 997.00M |
Total Debt | 81.00M |
Net Cash | 924.00M |
Net Cash Per Share | $8.73 |
Equity (Book Value) | 531.00M |
Book Value Per Share | 5.01 |
Working Capital | 839.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$300.00 million and capital expenditures -$3.00 million, giving a free cash flow of -$303.00 million.
Operating Cash Flow | -300.00M |
Capital Expenditures | -3.00M |
Free Cash Flow | -303.00M |
FCF Per Share | -$2.86 |
Full Cash Flow Statement Margins
Gross margin is -226.95%, with operating and profit margins of -309.22% and -277.30%.
Gross Margin | -226.95% |
Operating Margin | -309.22% |
Pretax Margin | -276.60% |
Profit Margin | -277.30% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.51% |
Shareholder Yield | n/a |
Earnings Yield | -44.60% |
FCF Yield | -34.56% |
Dividend Details Analyst Forecast
The average price target for RCUS is $25.33, which is 205.92% higher than the current price. The consensus rating is "Buy".
Price Target | $25.33 |
Price Target Difference | 205.92% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 28.05% |
EPS Growth Forecast (5Y) | -12.27% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.43 |
Piotroski F-Score | 2 |